{"id":228397,"date":"2026-09-02T16:56:55","date_gmt":"2026-09-02T11:26:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=228397"},"modified":"2026-09-02T16:56:57","modified_gmt":"2026-09-02T11:26:57","slug":"gland-pharma-share-price-usfda-inspection-2026-09-02","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/","title":{"rendered":"Gland Pharma Share Price in Focus as Visakhapatnam Facilities Clear USFDA Inspection With Zero Observations"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Gland Pharma share price Rs 2,874.20, up 0.20%. USFDA inspection at VSEZ facilities (24 Aug-1 Sep) concluded with zero Form 483 observations. Volume up 603.98% over 5-day average.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Gland Pharma share price rose 0.20 percent to Rs 2,874.20 on 2 September 2026, after the company announced that its Visakhapatnam sterile oncology formulations facility and API facility cleared a routine USFDA Good Manufacturing Practice inspection with zero Form 483 observations. The inspection was conducted between 24 August and 1 September 2026. A clean inspection outcome removes a key near-term regulatory overhang for the stock, and trading volumes surged over 600 percent above the five-day average, reflecting heightened investor interest in the development.<\/p>\n<\/div>\n<p>Gland Pharma share price rose 0.20 percent to Rs 2,874.20 on 2 September 2026, after the company confirmed that its Visakhapatnam Special Economic Zone sterile oncology formulations facility and API facility had cleared a routine US Food and Drug Administration inspection without any Form 483 observations. The inspection was carried out between 24 August and 1 September 2026.<\/p>\n<p>A zero-observation USFDA inspection outcome is a meaningful positive for Gland Pharma share price, since it removes near-term uncertainty around potential warning letters or import alerts that can disrupt supply to key US customers.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=art7\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#What_Did_the_USFDA_Inspection_at_Gland_Pharma_Cover\" title=\"What Did the USFDA Inspection at Gland Pharma Cover?\">What Did the USFDA Inspection at Gland Pharma Cover?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#Why_Does_a_Clean_USFDA_Inspection_Matter_for_Gland_Pharma_Share_Price\" title=\"Why Does a Clean USFDA Inspection Matter for Gland Pharma Share Price?\">Why Does a Clean USFDA Inspection Matter for Gland Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#Gland_Pharma_Company_Overview_and_Valuation\" title=\"Gland Pharma Company Overview and Valuation\">Gland Pharma Company Overview and Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#What_Should_Investors_Watch_for_Gland_Pharma_Going_Forward\" title=\"What Should Investors Watch for Gland Pharma Going Forward?\">What Should Investors Watch for Gland Pharma Going Forward?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#Why_did_Gland_Pharma_share_price_rise_today\" title=\"Why did Gland Pharma share price rise today?\">Why did Gland Pharma share price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#What_is_a_Form_483_observation\" title=\"What is a Form 483 observation?\">What is a Form 483 observation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#When_was_the_USFDA_inspection_at_Gland_Pharmas_Visakhapatnam_facility_conducted\" title=\"When was the USFDA inspection at Gland Pharma&#8217;s Visakhapatnam facility conducted?\">When was the USFDA inspection at Gland Pharma&#8217;s Visakhapatnam facility conducted?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#What_is_Gland_Pharmas_current_market_capitalisation\" title=\"What is Gland Pharma&#8217;s current market capitalisation?\">What is Gland Pharma&#8217;s current market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#Why_does_the_US_market_matter_so_much_for_Gland_Pharma\" title=\"Why does the US market matter so much for Gland Pharma?\">Why does the US market matter so much for Gland Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#What_is_Gland_Pharmas_price_to_earnings_ratio\" title=\"What is Gland Pharma&#8217;s price to earnings ratio?\">What is Gland Pharma&#8217;s price to earnings ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-usfda-inspection-2026-09-02\/#What_typically_follows_a_clean_USFDA_inspection\" title=\"What typically follows a clean USFDA inspection?\">What typically follows a clean USFDA inspection?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Did_the_USFDA_Inspection_at_Gland_Pharma_Cover\"><\/span><strong>What Did the USFDA Inspection at Gland Pharma Cover?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The United States Food and Drug Administration conducted a routine Good Manufacturing Practice inspection at Gland Pharma&#8217;s Visakhapatnam Special Economic Zone sterile oncology formulations facility and its API facility between 24 August and 1 September 2026. The inspection concluded with zero Form 483 observations, indicating the regulator found no deficiencies requiring corrective action at either facility.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Does_a_Clean_USFDA_Inspection_Matter_for_Gland_Pharma_Share_Price\"><\/span><strong>Why Does a Clean USFDA Inspection Matter for Gland Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma share price is closely tied to the company&#8217;s significant reliance on the US market, where regulatory compliance directly affects its ability to manufacture and supply products. A history of clean facility inspections, without major warning letters, has been a key differentiator for Gland Pharma share price within the Indian generic injectables space.<\/p>\n<p>Gland Pharma share price has historically seen sharp single-day moves around USFDA news. Trading volumes on 2 September 2026 stood at 87,170 shares, an increase of 603.98 percent over the five-day average of 12,382 shares, reflecting market attention to the development.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Gland_Pharma_Company_Overview_and_Valuation\"><\/span><strong>Gland Pharma Company Overview and Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma share price reflects a market capitalisation of around Rs 47,318 crore and a price to earnings ratio of 41.92, above the pharma sector average of 38.05. Return on equity stands at 9.92 percent, and the company operates as a subsidiary of China&#8217;s Fosun Pharma, with a footprint spanning over 60 countries.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Live Stock Data on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Watch_for_Gland_Pharma_Going_Forward\"><\/span><strong>What Should Investors Watch for Gland Pharma Going Forward?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors tracking Gland Pharma share price should watch for the Establishment Inspection Report that typically follows a clean USFDA visit, as well as progress on product registrations, where the company already has over 1,400 across international markets. Quarterly execution in Europe and the US remains an important catalyst for Gland Pharma share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma share price edged higher on 2 September 2026 after its Visakhapatnam facilities cleared a USFDA inspection with zero Form 483 observations, a clean outcome that reduces regulatory risk for a company reliant on the US injectables market. Gland Pharma share price saw trading volumes surging well above average, reflecting investor attention. Investors should assess valuation and consult a SEBI-registered advisor before making investment decisions.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live prices and get daily stock updates.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Gland_Pharma_share_price_rise_today\"><\/span><strong>Why did Gland Pharma share price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma share price rose 0.20 percent on 2 September 2026 after the company&#8217;s Visakhapatnam sterile oncology and API facilities cleared a routine USFDA inspection with zero Form 483 observations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_a_Form_483_observation\"><\/span><strong>What is a Form 483 observation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A Form 483 observation is a notice issued by the USFDA when inspectors observe conditions that may violate Good Manufacturing Practice requirements. A zero-observation outcome means no such deficiencies were found during the inspection.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_was_the_USFDA_inspection_at_Gland_Pharmas_Visakhapatnam_facility_conducted\"><\/span><strong>When was the USFDA inspection at Gland Pharma&#8217;s Visakhapatnam facility conducted?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The USFDA inspection at Gland Pharma&#8217;s Visakhapatnam Special Economic Zone facilities was conducted between 24 August and 1 September 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Gland_Pharmas_current_market_capitalisation\"><\/span><strong>What is Gland Pharma&#8217;s current market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma&#8217;s market capitalisation stood at approximately Rs 47,318 crore as of the latest available data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_does_the_US_market_matter_so_much_for_Gland_Pharma\"><\/span><strong>Why does the US market matter so much for Gland Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma is a generic injectables focused company with significant reliance on the US market, where regulatory compliance directly affects its ability to manufacture and supply products to customers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Gland_Pharmas_price_to_earnings_ratio\"><\/span><strong>What is Gland Pharma&#8217;s price to earnings ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma trades at a price to earnings ratio of around 41.92, above the broader pharma sector average of 38.05.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_typically_follows_a_clean_USFDA_inspection\"><\/span><strong>What typically follows a clean USFDA inspection?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A clean USFDA inspection is typically followed by an Establishment Inspection Report confirming closure of the inspection, which further reduces regulatory uncertainty for the company.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gland Pharma share price edged higher on 2 September 2026 after the company&#8217;s Visakhapatnam sterile oncology and API facilities cleared a USFDA inspection without a single Form 483 observation.<\/p>\n","protected":false},"author":28,"featured_media":228396,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-228397","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["228396"],"_edit_lock":["1788348420:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["78"],"rank_math_title":["Gland Pharma Share Price in Focus on Clean USFDA Report"],"rank_math_description":["Gland Pharma share price rose after its Visakhapatnam facilities cleared a USFDA inspection with zero Form 483 observations, easing regulatory overhang on the stock."],"rank_math_focus_keyword":["Gland Pharma share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["41142"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/gland-pharma-share-price-usfda-inspection-2026-09-02.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/228397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=228397"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/228397\/revisions"}],"predecessor-version":[{"id":228407,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/228397\/revisions\/228407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/228396"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=228397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=228397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=228397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}